Major US consumer group asks FDA to ban drug for diabetesBMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a2401 (Published 05 November 2008) Cite this as: BMJ 2008;337:a2401
- Janice Hopkins Tanne
- 1New York
Public Citizen, a US national consumer advocacy group, has petitioned the US Food and Drug Administration to ban the drug rosiglitazone (sold as Avandia), which is prescribed for type 2 diabetes.
The group said that liver failure, often fatal, was a newly documented risk with the drug, which is made by GlaxoSmithKline. Previously the drug had been linked to an increased risk of heart attacks, heart failure, bone fractures, and eye problems, Public Citizen said.
The drug now carries a “black box” warning from the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial